血清miR-148a、miR-1244联合磁共振成像检查对卵巢癌的诊断价值OA
Diagnostic value of serum miR-148a and miR-1244 combined with magnetic resonance imaging in ovarian cancer
目的 探讨血清miR-148a、miR-1244联合磁共振成像检查对卵巢癌的诊断价值.方法 选取2021年8月至2023年8月该院收治的108例卵巢癌患者作为卵巢癌组,另选取同期该院收治的102例卵巢良性疾病患者作为卵巢良性疾病组.采用实时荧光定量聚合酶链反应检测所有研究对象血清miR-148a、miR-1244水平.收集卵巢癌患者的基线资料.采用诊断四格表分析磁共振成像检查联合血清miR-148a、miR-1244对卵巢癌的诊断价值;绘制受试者工作特征(ROC)曲线分析血清miR-148a、miR-1244对卵巢癌的诊断价值,采用Kappa检验分析磁共振成像检查及血清miR-148a、miR-1244单独及三者联合诊断卵巢癌与病理检查结果的一致性.结果 卵巢癌组血清miR-148a、miR-1244水平均低于卵巢良性疾病组,差异均有统计学意义(P<0.05).年龄<60岁、国际妇产科联盟(FIGO)分期为Ⅰ~Ⅱ期、TNM分期为Ⅱ期、中高分化程度患者血清中miR-148a、miR-1244水平均高于年龄≥60岁、FIGO分期为Ⅲ~Ⅳ期、TNM分期为Ⅲ~Ⅳ期、低分化程度患者,差异均有统计学意义(P<0.05).ROC曲线分析结果显示,血清miR-148a诊断卵巢癌的最佳截断值为0.97,miR-1244诊断的最佳截断值为0.92.磁共振成像检查联合血清miR-148a、miR-1244检查结果与病理检查结果一致性较高,Kappa值为0.847(P<0.05).与磁共振成像检查、miR-148a、miR-1244单独诊断相比,三者联合诊断卵巢癌的灵敏度和准确度均较高,差异均有统计学意义(P<0.05).结论 卵巢癌患者血清miR-148a、miR-1244水平均降低,磁共振成像检查、miR-148a、miR-1244联合诊断卵巢癌的效能较单独诊断更好.
Objective To investigate the diagnostic value of serum miR-148a and miR-1244 combined with magnetic resonance imaging in ovarian cancer.Methods A total of 108 patients with ovarian cancer admitted to the hospital from August 2021 to August 2023 were selected as the ovarian cancer group,and 102 patients with benign ovarian disease admitted to the hospital during the same period were selected as the benign ovari-an disease group.Real-time fluorescence quantitative polymerase chain reaction was used to detect the serum levels of miR-148a and miR-1244 in all subjects.Baseline data of ovarian cancer patients were collected.The diagnostic value of magnetic resonance imaging combined with serum miR-148a and miR-1244 in ovarian canc-er was analyzed by diagnostic four-grid table.The receiver operating characteristic(ROC)curve was drawn to analyze the diagnostic value of serum miR-148a and miR-1244 in ovarian cancer.Kappa test was used to ana-lyze the consistency of magnetic resonance imaging examination,serum miR-148a,miR-1244 alone or in com-bination with pathological examination in the diagnosis of ovarian cancer.Results The serum levels of miR-148a and miR-1244 in the ovarian cancer group were lower than those in the benign ovarian disease group,and the differences were statistically significant(P<0.05).The serum levels of miR-148a and miR-1244 in pa-tients with age<60 years old,International Federation of Gynecology and Obstetrics(FIGO)stage Ⅰ-Ⅱ,TNM stage Ⅱ,and moderate and high differentiation were higher than those in patients with age ≥60 years old,FIGO stage Ⅲ-Ⅳ,TNM stage Ⅲ-Ⅳ,and low differentiation,and the differences were statistically sig-nificant(P<0.05).ROC curve analysis showed that the best cut-off value of serum miR-148a for the diagno-sis of ovarian cancer was 0.97,and the best cut-off value of serum miR-1244 for the diagnosis of ovarian canc-er was 0.92.The results of magnetic resonance imaging combined with serum miR-148a and miR-1244 were highly consistent with the results of pathological examination,and the Kappa value was 0.847(P<0.05).Compared with magnetic resonance imaging,miR-148a and miR-1244 alone,the sensitivity and accuracy of the combination of the three in the diagnosis of ovarian cancer were higher,and the differences were statistically significant(P<0.05).Conclusion The levels of serum miR-148a and miR-1244 in patients with ovarian canc-er are decreased.Magnetic resonance imaging examination,miR-148a and miR-1244 combined diagnosis of o-varian cancer is better than single diagnosis.
邓菁;苏洁敏;陈真;林春材;黄文荣
海南西部中心医院 放射科,海南儋州 571700海南西部中心医院 放射科,海南儋州 571700海南西部中心医院 妇科,海南儋州 571700海南西部中心医院 放射科,海南儋州 571700海南西部中心医院 放射科,海南儋州 571700
医药卫生
卵巢癌miR-148amiR-1244联合诊断磁共振成像
ovarian cancermiR-148amiR-1244combined diagnosismagnetic resonance imaging
《检验医学与临床》 2026 (17)
2366-2370,2376,6
海南省卫生健康行业科研项目(21A200308).
评论